mevalonic acid has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glogova, A; Haagsma, J; Pereira, M; Petrik, J; Shepherd, TG; Stewart, J | 1 |
| DiMattia, G; Greenaway, JB; Hardy, D; Osz, K; Petrik, J; Revay, T; Shepherd, T; Virtanen, C | 1 |
2 other study(ies) available for mevalonic acid and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
Topics: Animals; Carcinoma, Ovarian Epithelial; Epithelial Cells; Fallopian Tubes; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Ovarian Neoplasms; Simvastatin; Tumor Suppressor Protein p53 | 2023 |
Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
Topics: Animals; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Genomic Instability; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred C57BL; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polyisoprenyl Phosphates; Simvastatin; Tumor Microenvironment | 2016 |